Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Abraham

Showing results (531-540 of 1,061) with videos related to

Pageof 107
Sort By:
Molecular Cell|September 3, 2005
Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathwayYou-Wei Zhang, Diane M Otterness, Gary G Chiang, et al.
Applied Nursing Research : ANR|May 1, 1989
ICU family support group sessions: family members' perceived benefitsK A Sabo, C Kraay, E Rudy, et al.
ESC Heart Failure|June 23, 2026
Comprehensive Clinical Benefit of CCM in HFrEF Patients - a win-ratio analysis of FIX-HF-5C randomized trialRami Kahwash, Poying Lai, William T Abraham, et al.
Biochemistry|August 23, 2006
The FRB domain of mTOR: NMR solution structure and inhibitor designMarilisa Leone, Kevin J Crowell, Jinhua Chen, et al.
Cancer Research|September 15, 1999
Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeineJ N Sarkaria, E C Busby, R S Tibbetts, et al.
International Journal of Cardiology|July 13, 1999
Clinical and angiographic features in patients under 35 years with a first Q wave acute myocardial infarctionC S Thomas, G Cherian, M T Abraham, et al.
JACC. Heart Failure|March 4, 2017
Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE TrialMartin St John Sutton, Cecilia Linde, Michael R Gold, et al.
Journal of the American Society of Nephrology : JASN|June 1, 1992
Atrial natriuretic peptide and urinary cyclic guanosine monophosphate in patients with chronic heart failureW T Abraham, J Hensen, J K Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
Vav-1 and the IKK alpha subunit of I kappa B kinase functionally associate to induce NF-kappa B activation in response to CD28 engagementEnza Piccolella, Francesca Spadaro, Carlo Ramoni, et al.
Molecular Cancer Therapeutics|September 4, 2007
The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional culturesAmy L Howes, Gary G Chiang, Elizabeth S Lang, et al.
Pageof 107

Showing results (531-540 of 1,061) with videos related to

Sort By:
Pageof 107
Molecular Cell|September 3, 2005
Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathwayYou-Wei Zhang, Diane M Otterness, Gary G Chiang, et al.
Applied Nursing Research : ANR|May 1, 1989
ICU family support group sessions: family members' perceived benefitsK A Sabo, C Kraay, E Rudy, et al.
ESC Heart Failure|June 23, 2026
Comprehensive Clinical Benefit of CCM in HFrEF Patients - a win-ratio analysis of FIX-HF-5C randomized trialRami Kahwash, Poying Lai, William T Abraham, et al.
Biochemistry|August 23, 2006
The FRB domain of mTOR: NMR solution structure and inhibitor designMarilisa Leone, Kevin J Crowell, Jinhua Chen, et al.
Cancer Research|September 15, 1999
Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeineJ N Sarkaria, E C Busby, R S Tibbetts, et al.
International Journal of Cardiology|July 13, 1999
Clinical and angiographic features in patients under 35 years with a first Q wave acute myocardial infarctionC S Thomas, G Cherian, M T Abraham, et al.
JACC. Heart Failure|March 4, 2017
Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE TrialMartin St John Sutton, Cecilia Linde, Michael R Gold, et al.
Journal of the American Society of Nephrology : JASN|June 1, 1992
Atrial natriuretic peptide and urinary cyclic guanosine monophosphate in patients with chronic heart failureW T Abraham, J Hensen, J K Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
Vav-1 and the IKK alpha subunit of I kappa B kinase functionally associate to induce NF-kappa B activation in response to CD28 engagementEnza Piccolella, Francesca Spadaro, Carlo Ramoni, et al.
Molecular Cancer Therapeutics|September 4, 2007
The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional culturesAmy L Howes, Gary G Chiang, Elizabeth S Lang, et al.
Pageof 107